The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease

Authors

Siyan Cao, Washington University School of Medicine in St. Louis
Jose L. Fachi, Washington University School of Medicine in St. Louis
Kaiming Ma, Washington University School of Medicine in St. Louis
Alina Ulezko Antonova, Washington University School of Medicine in St. Louis
Qianli Wang, Washington University School of Medicine in St. Louis
Zhangying Cai, Washington University School of Medicine in St. Louis
Randal J. Kaufman, Sanford Burnham Prebys Medical Discovery Institute
Matthew A. Ciorba, Washington University School of Medicine in St. Louis
Parakkal Deepak, Washington University School of Medicine in St. Louis
Marco Colonna, Washington University School of Medicine in St. Louis

Journal

Journal of Clinical Investigation

Publication Date

5-9-2024

Volume

134

Issue

13

First Page

e174198

Document Type

Open Access Publication

DOI

10.1172/JCI174198

Rights and Permissions

Cao S, Fachi JL, Ma K, Ulezko Antonova A, Wang Q, Cai Z, Kaufman RJ, Ciorba MA, Deepak P, Colonna M. The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease. J Clin Invest. 2024 May 9;134(13):e174198. doi: 10.1172/JCI174198. © 2024, Cao et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Recommended Citation

Cao, Siyan; Fachi, Jose L.; Ma, Kaiming; Ulezko Antonova, Alina; Wang, Qianli; Cai, Zhangying; Kaufman, Randal J.; Ciorba, Matthew A.; Deepak, Parakkal; and Colonna, Marco, "The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease." Journal of Clinical Investigation. 134, 13. e174198 (2024).
https://digitalcommons.wustl.edu/oa_4/3905

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.